Strides Pharma Science Quarterly Results for Trading Insights

STAR • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹132 Cr
QSept 2025
Quarterly Results

Strides Pharma Science Quarterly Results Key Highlights

  • Revenue of ₹1,248 Cr in Sept 2025 (+3.5% vs Mar 2025, +4.4% vs Sept 2024)
  • Net Profit of ₹132 Cr in Sept 2025 (+53.5% vs Mar 2025, +83.3% vs Sept 2024)
  • EBITDA of ₹249 Cr in Sept 2025 (+20.9% vs Mar 2025)
  • Operating Margin of 18.0% in Sept 2025 (+2.0pp vs Mar 2025)
  • Earnings Per Share of ₹13.84 in Sept 2025 (+55.2% vs Mar 2025)

Strides Pharma Science Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 1,248 1,206 1,128 1,302 1,195 3.5% 4.4%
Net Profit (₹ Cr) 132 86 106 208 72 - -
EBITDA (₹ Cr) 249 206 218 340 209 - -
EPS (₹) 13.84 8.92 10.81 21.93 7.81 - -
Operating Margin (%) 18.0% 16.0% 19.0% 19.0% 15.0% - -

Strides Pharma Science Share Price Trend Around Quarterly Results

Visualize Strides Pharma Science's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Strides Pharma Science

Additional stock information and data for STAR

STAR stock overview
Strides Pharma Science P/E valuation
STAR yearly price range

Profitability Ratios

Profit Margin 10.6%
EBITDA Margin 20.0%
Operating Margin 18.0%
ROE (Annual) 20.4%

Balance Sheet Highlights

Total Assets ₹6,049 Cr
Total Equity ₹2,587 Cr
Current Assets ₹3,099 Cr
Current Liabilities ₹871 Cr

Cash Flow Analysis

Operating Cash Flow ₹684 Cr
Investing Cash Flow ₹-90 Cr
Financing Cash Flow ₹-643 Cr
Net Cash Flow ₹-49 Cr

Current Market Data

Current Price ₹964.40
Exchange NSE
Last Updated Apr 08, 2026

Revenue Trend (₹ Cr)

Dec 2025 1,302
Jun 2025 1,128
Mar 2025 1,206
Sept 2025 1,248

Net Profit Trend (₹ Cr)

Dec 2025 208
Jun 2025 106
Mar 2025 86
Sept 2025 132

Operating Margin Trend (%)

Dec 2025 19.0%
Jun 2025 19.0%
Mar 2025 16.0%
Sept 2025 18.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Strides Pharma Science quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1714.6 14,875 3,125 +10.8% - 21.0% 131.9
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5882.0 2,860 689 +7.1% - 24.1% 226.5
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4029.2 3,219 591 +11.3% - 18.4% 229.7
Lupin
Sept 2025 		₹102,578.78 Cr 2294.1 6,921 1,485 +23.2% - 21.5% 70.9
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1191.4 9,135 1,337 +1.1% - 14.6% 73.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores